Of note, while glutamine dependence underlies the resistance to the BRAF inhibitor (59), local deprivation of glutamine in melanoma TME increases histone hyper-methylation, which contributes to tumor cell dedifferentiation and also results in resistance to BRAF inhibitor treatment (60). Here, BRAF is linked to melanoma.